E-Pharma Trento acquired by Wise Equity
Wise Equity agreed to acquire E-Pharma Trento, an Italian pharmaceutical manufacturing brand, on Aug 7, 2026.
Transaction summary
- Target
- E-Pharma Trento
- Acquirer
- Wise Equity Investor profile →
- Seller
- -
- Announced
- 2026-08-07
- Geography
- Italy
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- 100%
- First added
- 2026-08-08
- Latest update
- 2026-11-03
Parties at the deal date
Acquirer
Current investor profile →Snapshot preserved for this transaction; current company profiles may differ.
Value and multiples
100% enterprise value
Undisclosed
Value not disclosed
Basis: FundComb estimate
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Enterprise value is unavailable.
Source summary
Wise Equity inks agreement to acquire E-Pharma Trento | PE Hub
ConfirmedPE Hub reports Wise Equity signed an agreement to acquire E-Pharma Trento, which may pursue bolt-on acquisitions to add technologies or enhance manufacturing capacity.
Open sourceContinue your research
Related transaction comps
Capsugel S.A. acquired by Lonza Group
2016-12-15 · Confirmed
View transaction → Pharma ServicesViatris OTC business acquired by Cooper Consumer Health
2023-10-01 · Confirmed
View transaction → PharmaSofie Biosciences acquired by GE HealthCare
2026-10-05 · Confirmed
View transaction → Pharma ServicesClario Holdings, Inc. acquired by Thermo Fisher Scientific
2025-10-29 · Confirmed
View transaction →